Researchers at Lancaster University have developed a new material that can store energy for months, and potentially years, at a time. The material can be activated by light, and then release the pent-up energy on demand in the form of heat.
The team started with a metal-organic framework (MOF), materials that are famous for being very porous and as such, having an extremely high surface area. That in turn allows them to hold onto large amounts of molecules, making them great for desalinating or filtering water, capturing carbon dioxide out of the air, or delivering drugs in the body.
For the new study, the Lancaster researchers tested out how well a MOF might be able to store energy. They started with a version of the material called a DMOF1, and loaded its pores with azobenzene molecules. This compound is excellent at absorbing light, which causes its molecules to physically change shape.
Here the video of the first discussion panel out of two, during the celebration of the Healthy Masters Conference 2020, which took place on November 29, 2020. Nuno Martins, organizer and moderator of the event, asked all panelists to comment on the following theme: What can we do to improve our health and longevity. Given the essence of the event, the question was surrounded by the objective of achieving radical life extension or super longevity. My intervention starts at minute 20:13 and in the description of the video there are all the time marks that direct to the begining of each talk.
First discussion panel out of two, during the celebration of the Healthy Masters Conference 2020 which took place on November 29, 2020. Nuno Martins, PhD, organizer and moderator of the event, asked all panelists to comment on the following theme: What can we do to improve our health and longevity? Given the essence of the event, the question was surrounded by the objective of achieving radical life extension or super longevity.
Panelists in order of appereance: * Naveen Jain: Founder and CEO of Moon Express Viome (00:21) * Nichola Conlon, PhD: CEO & Founder of Nuchido (03:28) * Kelsey Moody, PhD: Process Oriented Drug Developer and Executive (05:18) * Peter Fedichev, PhD: Head of the Laboratory of Biological Systems (08:38) * James Hughes, PhD: Executive Director of the Institute for Ethics and Emerging Technologies (12:12) * María Entraigues Abramson: Global Outreach Coordinator for the SENS Research Foundation (15:14) * Yael Sorek-Benvesti, PhD: CEO of Mediterranean Towers Venture (18:24) * Andrés Grases, MBA: Owner and Editor of Transhumanplus.com (20:13) * Ines O´Donovan: Founder of the Jeunessima Lifestyle Company (23:52) * Reason, CEO of Repair Biotecnologies (27:39) * Odette Tonnae: Founder of YOAKE, the Healthy Lifestyle Expertise. Simulation at MIPT (31:53)
Fable Studio has announced two new conversational AI virtual beings, or artificial people. Their names are Charlie and Beck, and they will be able to hold conversations as if they were real people.
The new characters are a blend of storytelling and artificial intelligence, a marriage that Fable is pioneering in the belief that virtual beings will become a huge market as people seek companionship and entertainment during the tough climate of the pandemic.
CEO Edward Saatchi believes that virtual beings are the start of something big. He organizes the Virtual Beings Summit, and this summer he noted that virtual beings companies — from Genies to AI Foundation — have raised more than $320 million.
Just as engineers once compressed some of the power of room-sized mainframes into desktop PCs, so too have Stanford researchers shown how to pack some of the punch delivered by today’s ginormous particle accelerators onto a tiny silicon chip.
Denmark culled 17 million minks in November in response to Covid-19 outbreaks at more than 200 mink farms. Now the country plans to dig up the dead animals after they started to rise out of their shallow graves.
The journey to see future technology starts in 2022, when Elon Musk and SpaceX send the first Starship to Mars — beginning the preparations for the arrival of the first human explorers.
We see the evolution of space exploration, from NASA’s Artemis mission, humans landing on Mars, and the interplanetary internet system going online. To the launch of the Starshot Alpha Centauri program, and quantum computers designing plants that can survive on Mars.
On Earth, tech evolves with quantum computers and Neaulink chips. People begin living with bio-printed organs. Humans record every part of lives from birth. And inner speech recording becomes possible.
And what about predictions further out into the future, when humans become level 2 and level 3 civilizations. When NASA’s warp drive goes live, and Mars declares independence from Earth. Will there be Dyson structures built around stars to capture their energy. Will they help power computers that can take human consciousness and download it into a quantum computer core. Allowing humanity to travel further out into space.
Quotes about the future from: Arthur C. Clarke, Stephen Hawking, Albert Einstein, and Elon Musk.
ANCHORAGE, Alaska (Reuters) — A Fairbanks clinician suffered anaphylactic symptoms after being given the Pfizer Inc coronavirus vaccine, a hospital said on Friday, becoming the third Alaska health care worker to suffer an adverse reaction to the new drug. The clinician, whose name was not released, started showing symptoms about 10 minutes after being inoculated on Thursday, according to Foundation Health Partners, operator of the Fairbanks Memorial Hospital. The health care worker was treated in the hospital’s emergency room with epinephrine and released about six hours later, Foundation Health Partners said in a written statement. “Allergic reactions, though uncommon, can occur with injections of medications and vaccines,” Foundation Health Partners’ Chief Medical Officer Dr. Angelique Ramirez said in the statement.
“A reactogenic vaccine is not the same thing as an unsafe vaccine,” says Saad Omer, a vaccinologist and the director of the Yale Institute for Global Health.”
The COVID-19 vaccine will make some people feel sick. But they’re not—that’s the immune system doing its job.
As we sit here in 2020, in the middle of a major viral pandemic, we can’t forget the fact that a century after the first antibiotics were created, drug resistant bacterial infections have become a major threat around the globe, exactly at the same time that the antibiotic pipelines of pharma companies have either dried up, or they have gotten out of the business.
In the U.S. alone, Centers For Disease Control (CDC) estimates that antibiotic resistance causes more than 2 million infections, several million hospital stay days, and over 35, 000 deaths per year. Worldwide, such infections cause 750, 000 deaths every year. And a recent United Nations (UN) report concluded that by 2050, “super bugs” could kill 10 million people globally every year, if no action is taken to combat the problem.
A solution to this emerging threat lies in the area of bacteriophage therapy (or “phage” for short), which is a type of virus that infects, replicates within, and are very good at killing bacteria.
Interestingly, phages have been used for over 90 years as an alternative to antibiotics in the former Soviet Union and Central Europe as well as in France. They are seen as a possible therapy against multi-drug-resistant strains of many bacteria and have been shown to interfere not just with bacteria life cycles, but also with biofilm production and quorum sensing involved bacterial colonization processes.
Dr. Robert Schooley, MD, is a Professor of Medicine, in the Division of Infectious Diseases and Global Public Health, at UC San Diego, the Co-Director of their Center for Innovative Phage Applications and Therapeutics (IPATH), as well as Interim Faculty Director, Global Education and Senior Director, International Initiatives.
Dr. Schooley is a graduate of the Johns Hopkins University School of Medicine. He completed an internal medicine residency at the Johns Hopkins Hospital and infectious disease fellowships at the National Institute of Allergy and Infectious Diseases and the Massachusetts General Hospital.
Emerging and reemerging infections present an ever-increasing challenge to global health. Here, we report a nanoparticle-enabled smartphone (NES) system for rapid and sensitive virus detection. The virus is captured on a microchip and labeled with specifically designed platinum nanoprobes to induce gas bubble formation in the presence of hydrogen peroxide. The formed bubbles are controlled to make distinct visual patterns, allowing simple and sensitive virus detection using a convolutional neural network (CNN)-enabled smartphone system and without using any optical hardware smartphone attachment. We evaluated the developed CNN-NES for testing viruses such as hepatitis B virus (HBV), HCV, and Zika virus (ZIKV). The CNN-NES was tested with 134 ZIKV-and HBV-spiked and ZIKV-and HCV-infected patient plasma/serum samples. The sensitivity of the system in qualitatively detecting viral-infected samples with a clinically relevant virus concentration threshold of 250 copies/ml was 98.97% with a confidence interval of 94.39 to 99.97%.
See allHide authors and affiliations.
Smartphone systems can also benefit from the recent unprecedented advancements in nanotechnology to develop diagnostic approaches. Catalysis can be considered as one of the popular applications of nanoparticles because of their large surface-to-volume ratio and high surface energy (11–16). So far, numerous diagnostic platforms for cancer and infectious diseases have been developed by substituting enzymes, such as catalase, oxidase, and peroxidase with nanoparticle structures (17–20). Here, we adopted the intrinsic catalytic properties of platinum nanoparticles (PtNPs) for gas bubble formation to detect viruses on-chip using a convolutional neural network (CNN)–enabled smartphone system.
